Form 4: Director Christopher Payne Increases HIMS Stake

Director Christopher D. Payne acquired 14,343 shares of Hims & Hers Health, Inc. through the vesting of Restricted Stock Units.

Summary

• Director Christopher D. Payne acquired a total of 14,343 shares of Class A Common Stock through the vesting of Restricted Stock Units (RSUs).
• 3,656 shares vested on June 11, 2026, related to annual meeting service requirements.
• 10,040 shares vested on June 15, 2026, as part of a 3-year service-based vesting schedule.
• 647 shares vested on June 15, 2026, issued in lieu of director retainer and committee fees for Q1 2026.
• Following these transactions, the director holds 34,318 shares directly and 110,000 shares indirectly via The Payne Family Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation and equity ownership.

Positives

• Increased equity alignment between the director and shareholders.
• Director opted to receive compensation in equity rather than cash, signaling confidence in the company's long-term value.

Negatives

• None identified; this is a standard equity compensation vesting event.

Risks

• General market volatility affecting the value of equity holdings.

Future Outlook

The filing indicates ongoing service-based vesting for remaining RSUs, with the next tranche of the 3-year grant scheduled to vest on May 15, 2027.

Management Comments

• The transactions reflect the conversion of contingent RSU rights into common stock as part of the established Director Compensation Policy.

Industry Context

StockSavvy.ai notes that director equity compensation in lieu of cash is a common practice in the telehealth and digital health sector to preserve cash flow while incentivizing board members.

Comparison to Industry Standards

• The use of RSUs for director compensation is consistent with standard corporate governance practices for mid-cap growth companies.
• The 3-year vesting schedule aligns with industry benchmarks for long-term incentive plans.

Stakeholder Impact

• Increased share ownership by a director generally signals positive internal sentiment to shareholders.

Next Steps

• Final tranche of 10,040 RSUs scheduled to vest on May 15, 2027.

Key Dates

Keywords

HIMS, Hims & Hers Health, Insider Trading, Form 4, Director Compensation, Equity Vesting